Rapid Nutrition Reports Half-Year Unaudited Results and Outlines Strategic Growth Initiatives
Accelerated debt repayment, positive subscription model growth, and expansion in China set the stage for future growth.
London, United Kingdom – 21 October 2024 - Rapid Nutrition PLC (Euronext Growth Paris: ALRPD), a global leader in natural wellness products, is pleased to release is H1 unaudited results.
Key Highlights:
- Rapid Nutrition accelerates debt repayment, on track to clear convertible loan notes by December 2024.
- Successful restructuring of SystemLS brand drives early revenue growth from newly optimized platform.
- Local manufacturing in China lays the groundwork for future expansion in the region.
Accelerated Debt Repayment
Rapid Nutrition’s management team has accelerated its debt repayment plan. The company expects to fully repay its convertible loan notes by December 2024, four months ahead of schedule, minimizing future financial obligations and positioning the company for stronger financial performance in the second half of the year.
Promising Growth in Subscription Model
The shift to a subscription-based model has shown early promise, with over 200 customers already on monthly plans. This model not only improves customer retention but also provides long-term revenue predictability. Subscription models are also known to attract higher market valuations, giving investors more confidence in the company's growth potential.
Outlook for Continued Growth
Rapid Nutrition is confident that the strategic decisions made in the first half of the year—including the move to a subscription model and the accelerated repayment of debt—will drive sustained growth in the second half of 2024 and beyond.
Investors and stakeholders can access the full report on the company website
For more information about Rapid Nutrition PLC and its product offerings, including market insights, please visit www.rnplc.com.
About Rapid Nutrition
Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).